Precision BioSciences, Inc. (DTIL)
7.78
-0.62
(-7.38%)
USD |
NASDAQ |
Aug 28, 16:00
7.80
+0.02
(+0.26%)
After-Hours: 20:00
Precision BioSciences Total Liabilities (Quarterly) : 80.63M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.63M |
| March 31, 2026 | 67.79M |
| December 31, 2025 | 62.17M |
| September 30, 2025 | 76.88M |
| June 30, 2025 | 74.87M |
| March 31, 2025 | 75.07M |
| December 31, 2024 | 80.00M |
| September 30, 2024 | 88.39M |
| June 30, 2024 | 91.09M |
| March 31, 2024 | 147.54M |
| December 31, 2023 | 140.92M |
| September 30, 2023 | 135.28M |
| June 30, 2023 | 147.66M |
| March 31, 2023 | 164.32M |
| December 31, 2022 | 177.74M |
| September 30, 2022 | 187.35M |
| June 30, 2022 | 194.14M |
| March 31, 2022 | 111.69M |
| Date | Value |
|---|---|
| December 31, 2021 | 120.33M |
| September 30, 2021 | 125.76M |
| June 30, 2021 | 129.56M |
| March 31, 2021 | 203.49M |
| December 31, 2020 | 105.73M |
| September 30, 2020 | 104.86M |
| June 30, 2020 | 98.59M |
| March 31, 2020 | 99.17M |
| December 31, 2019 | 96.92M |
| September 30, 2019 | 104.51M |
| June 30, 2019 | 97.94M |
| March 31, 2019 | 155.97M |
| December 31, 2018 | 98.64M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 99.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.95B |
| 4D Molecular Therapeutics, Inc. | 84.96M |
| Agenus, Inc. | 378.54M |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.92M |
| Shareholders Equity (Quarterly) | 45.29M |
| Debt to Equity Ratio | 0.6204 |
| Current Ratio | 12.82 |
| Net Debt Paydown Yield | 0.16% |